AstraZeneca PLC is 182.6x more valuable than AbCellera Biologics Inc. by market capitalization ($286.27 B vs $1.57 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABCL | AZN |
|---|---|---|
| Market cap | $1.57 B | $286.27 B |
| US-listed rank | #2295 | #45 |
| Revenue (latest FY) | $75.13M | - |
| Net income (latest FY) | -$146.41M | - |
| Net margin | -194.9% | - |
| SEC filings | 297 | 1,004 |
AstraZeneca PLC is 182.6x more valuable than AbCellera Biologics Inc. by market capitalization ($286.27 B vs $1.57 B).
Full pages: AbCellera Biologics Inc. and AstraZeneca PLC, or browse the full rankings.